Institutional | news_types | eHealth News | Page 367

The Fenix Continence Restoration System has been approved by the U.S. Food and Drug Administration to treat an inability to control bowel movements for patients who can't tolerate or use other approved methods.

FDA Approves New Device for Fecal Incontinence

HealthDay.com - Dec 18, 2015 0

Viable surgical option when medical measures have failed

The LifeVest wearable defibrillator has been approved by the U.S. Food and Drug Administration for children at risk for cardiac arrest who can't have a defibrillator implanted. The device is already approved for adults.

FDA Approves LifeVest Wearable Defibrillator for Children

HealthDay.com - Dec 17, 2015 0

For heart patients who can't have device implanted

Bridion (sugammadex) has been approved by the U.S. Food and Drug Administration to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide.

FDA Approves Bridion to Reverse Neuromuscular Blockade

HealthDay.com - Dec 16, 2015 0

Drug reverses the effects of rocuronium bromide and vecuronium bromide

All adults and teens at increased risk for syphilis should be screened for the sexually transmitted disease

USPSTF: Screen All Teens, Adults at Risk for Syphilis

HealthDay.com - Dec 15, 2015 0

Proposed recommendation dovetails with surge in U.S. cases of the sexually transmitted disease

The U.S. abortion rate has declined by more than one-third over the past two decades to a record low

CDC: U.S. Abortion Rate Hits Record Low

HealthDay.com - Dec 14, 2015 0

In 2010, for every 100 pregnancies, 65 ended in birth, 18 in abortion, and 17 in fetal loss

Vistogard (uridine triacetate) has been approved by the U.S. Food and Drug Administration to treat an overdose of the chemotherapy drugs fluorouracil and capecitabine

FDA Approves Vistogard to Treat Chemotherapy Overdose

HealthDay.com - Dec 11, 2015 0

For overdose of the chemo drugs fluorouracil and capecitabine

Alecensa (alectinib) has been approved by the U.S. Food and Drug administration to treat anaplastic lymphoma kinase-positive non-small-cell lung cancer

FDA Approves Alecensa for ALK-Positive NSCLC

HealthDay.com - Dec 11, 2015 0

Drug is designed to block the effects of the ALK protein

The Dignitana DigniCap Cooling System cap has been approved by the U.S. Food and Drug Administration to help prevent hair loss in women undergoing chemotherapy for breast cancer.

FDA Approves Cooling Cap to Reduce Chemo-Linked Hair Loss

HealthDay.com - Dec 9, 2015 0

Designed for women diagnosed with breast cancer

Fewer American families are struggling to pay medical bills

CDC: Fewer Americans Struggling With Medical Bills

HealthDay.com - Dec 8, 2015 0

U.S. report shows 12 million are no longer in families having trouble paying for health care

Kanuma (sebelipase alfa) has been approved by the U.S. Food and Drug Administration as the first treatment for LAL deficiency (Wolman disease or cholesteryl ester storage disease).

FDA Approves Kanuma for Lysosomal Acid Lipase Deficiency

HealthDay.com - Dec 8, 2015 0

For treatment of LAL deficiency, also known as Wolman disease or cholesteryl ester storage disease

1...366367368...398 Page 367 of 398

Archives